Biblio

135 resultats trouvés
Filtres: Auteur is Wendling, D.  [Clear All Filters]
D
Godfrin-Valnet M., Puyraveau M., Wendling D..  2014.  DEFINING FLARE IN SPONDYLOARTHRITIS: THRESHOLDS OF DISEASE ACTIVITY VARIATIONS. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 32:795.
Fakih O., Chouk M., Prati C., Wendling D., Verhoeven F..  2021.  DESCRIPTION OF SACROILIAC CT FINDINGS IN PATIENTS WITH ANKYLOSING SPONDYLITIS AGED OVER 50 YEARS: PRELIMINARY RESULTS OF THE CASIAGE STUDY. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 39:1204-1205.
Fakih O., Chouk M., Prati C., Wendling D., Verhoeven F..  2021.  DESCRIPTION OF SACROILIAC CT FINDINGS IN PATIENTS WITH ANKYLOSING SPONDYLITIS AGED OVER 50 YEARS: PRELIMINARY RESULTS OF THE CASIAGE STUDY. ANNALS OF THE RHEUMATIC DISEASES. 80:748-749.
Ramon A., Fayolle C., Devilliers H., Piroth C., Herrada I., Attane G., Wendling D., Ornetti P..  2020.  DIAGNOSTIC PERFORMANCE OF VARIOUS CLASSIFICATION CRITERIA IN LOW BACK PAIN PATIENTS WITH SUSPECTED AXIAL SPONDYLOARTHRITIS: A PRAGMATIC STUDY.. ANNALS OF THE RHEUMATIC DISEASES. 79:1650.
Molto A., S. Montcel Tdu, Wendling D., Dougados M., Vanier A., Gossec L..  2015.  DISEASE ACTIVITY TRAJECTORIES IN EARLY AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE DESIR COHORT. ANNALS OF THE RHEUMATIC DISEASES. 74:779.
Monet M., Prati C., Guillot X., Sondag M., Verhoeven F., Aubin F., Wendling D..  2018.  DISEASE MODIFYING ANTI RHEUMATIC DRUGS IN THE TREATMENT OF SAPHO SYNDROME: SYSTEMATIC LITERATURE ANALYSIS. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 36:721.
Monet M., Prati C., Guillot X., Sondag M., Verhoeven F., Aubin F., Wendling D..  2018.  DISEASE MODIFYING ANTI RHEUMATIC DRUGS IN THE TREATMENT OF SAPHO SYNDROME: SYSTEMATIC LITERATURE ANALYSIS. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 36:721.
Monet M., Prati C., Guillot X., Sondag M., Verhoeven F., Aubin F., Wendling D..  2018.  DISEASE MODIFYING ANTI RHEUMATIC DRUGS IN THE TREATMENT OF SAPHO SYNDROME: SYSTEMATIC LITERATURE ANALYSIS. ANNALS OF THE RHEUMATIC DISEASES. 77:1155-1156.
E
Bordy R., Totoson P., Verhoeven F., Wendling D., Demougeot C..  2019.  Effect of a chronic treatment with an arginase inhibitor on cerebrovascular endothelial dysfunction in Adjuvant-Induced Arthritis. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 33:52.
Bordy R., Totoson P., Verhoeven F., Wendling D., Demougeot C..  2019.  Effect of a chronic treatment with an arginase inhibitor on cerebrovascular endothelial dysfunction in Adjuvant-Induced Arthritis. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 33:52.
Hecquet S., Verhoeven F., Aubry S., Prati C., Wendling D..  2020.  EFFECTIVENESS OF SACROPLASTY IN THE MANAGEMENT OF OSTEOPOROTIC SACRAL FRACTURE IN ELDERLY PATIENTS. ANNALS OF THE RHEUMATIC DISEASES. 79:1747-1748.
Gueugnon M., Fournel I, Soilly A-L, Diaz A., Baulot E., Bussiere C., Casillas J.M, Cherasse A., Conrozier T., Loeuille D. et al..  2021.  Effectiveness, safety, and cost-utility of a knee brace in medial knee osteoarthritis: the ERGONOMIE randomized controlled trial. OSTEOARTHRITIS AND CARTILAGE. 29:491-501.
Verhoeven F., Prati C., Wendling D., Demougeot C..  2016.  EFFECTS OF GLUCOCORTICOIDS ON ENDOTHELIAL FUNCTION: FOCUS ON RHEUMATOID ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. 75:992.
Bordy R., Pasquereau S., Abbas W., Kumar A., Verhoeven F., Prati C., Wendling D., Herbein G., Demougeot C., Totoson P..  2021.  Effects of glucocorticoids on sirtuin 1 pathway in rheumatoid arthritis. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 35:151.
Diaz A., Morisset C., Fournel I., Soilly A.-L, Bussiere C., Cherasse A., Conrozier T., Loeuille D., Timsit M., Wendling D. et al..  2018.  EFFICACY AND SAFETY OF A DISTRACTION-ROTATION KNEE BRACE (ODRA) IN MEDIAL KNEE OSTEOARTHRITIS - A PHASE III RANDOMISED CONTROLLED TRIAL (ERGONOMIE STUDY). ANNALS OF THE RHEUMATIC DISEASES. 77:79.
Pers Y.-M, Schaub R., Fortunet C., Constant E., Lambert J., Godfrin-Valnet M., Pallot-Prades B., Wendling D., Gaudin P., Marotte H. et al..  2014.  EFFICACY AND SAFETY OF TOCILIZUMAB IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. 73:689.
Sondag M., Verhoeven F., Guillot X., Prati C., Wendling D..  2018.  EFFICACY OF NEW TREATMENTS ON DACTYLITIS OF PSORIATIC ARTHRITIS: UPDATE OF SYSTEMATIC LITERATURE REVIEW. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 36:723.
Sondag M., Verhoeven F., Guillot X., Prati C., Wendling D..  2018.  EFFICACY OF NEW TREATMENTS ON DACTYLITIS OF PSORIATIC ARTHRITIS: UPDATE OF SYSTEMATIC LITERATURE REVIEW. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 36:723.
Sondag M., Verhoeven F., Guillot X., Prati C., Wendling D..  2018.  EFFICACY OF NEW TREATMENTS ON DACTYLITIS OF PSORIATIC ARTHRITIS: UPDATE OF SYSTEMATIC LITERATURE REVIEW. ANNALS OF THE RHEUMATIC DISEASES. 77:1593.
Totoson P., Maguin-Gate K., Monnier A., Tessier A., Marie C., Prati C., Wendling D., Demougeot C..  2015.  Etanercept improves endothelial function in Rat Adjuvant-Induced Arthritis: mechanisms involved. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 29:2.
Laustriat G., Fogel O., Wendling D., Ottaviani S., Guignard S., Morel J., Gottenberd J.E, Cantagrel A., CRI.  2018.  EVALUATION OF RITUXIMAB, TOCILIZUMAB AND ABATACEPT IN A FRENCH MULTICENTER RHUPUS COHORT. ANNALS OF THE RHEUMATIC DISEASES. 77:604-605.
Brinster A., Guillot X., Prati C., Wendling D..  2016.  EVOLUTION OVER THIRTY YEARS OF THE PROFILE OF IN-PATIENTS WITH REACTIVE ARTHRITIS IN A TERTIARY RHEUMATOLOGY UNIT. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 34:733.
Brinster A., Guillot X., Prati C., Wendling D..  2016.  EVOLUTION OVER THIRTY YEARS OF THE PROFILE OF IN-PATIENTS WITH REACTIVE ARTHRITIS IN A TERTIARY RHEUMATOLOGY UNIT. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 34:733.
Brinster A., Guillot X., Prati C., Wendling D..  2016.  EVOLUTION OVER THIRTY YEARS OF THE PROFILE OF INPATIENTS WITH REACTIVE ARTHRITIS IN A TERTIARY RHEUMATOLOGY UNIT. ANNALS OF THE RHEUMATIC DISEASES. 75:1136.
F
L. Vegas P, Sbidian E., Wendling D., Goupille P., Ferkal S., Le Corvoisier P., Ghaleh B., Luciani A., Claudepierre P..  2021.  FACTORS ASSOCIATED WITH REMISSION AT 5 YEARS OF FOLLOW-UP IN EARLY ONSET AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE DESIR COHORT. ANNALS OF THE RHEUMATIC DISEASES. 80:27-28.

Pages